Matrix metalloproteases and lung disease.
暂无分享,去创建一个
[1] D. Demello,et al. Hyperoxia induces interstitial (type I) and increases type IV collagenase mRNA expression and increases type I and IV collagenolytic activity in newborn rat lung. , 1994, Biology of the neonate.
[2] T. Tetley. New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease. , 1993, Thorax.
[3] H. Birkedal‐Hansen,et al. Role of Matrix Metalloproteinases in Human Periodontal Diseases. , 1993, Journal of periodontology.
[4] Y. Soini,et al. Genes of laminin B1 chain, alpha 1 (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas. , 1993, The American journal of pathology.
[5] D. Miles,et al. Activity of type IV collagenases in benign and malignant breast disease. , 1993, British Journal of Cancer.
[6] S. Zucker,et al. Tetracycline and doxycycline inhibit pleural fluid metalloproteinases. A possible mechanism for chemical pleurodesis. , 1993, Chest.
[7] R. Strieter,et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups , 1993, The Lancet.
[8] H. Birkedal‐Hansen,et al. Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[9] Y. Okada,et al. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema , 1992, Cell.
[10] S. Zucker,et al. Human pleural effusions are rich in matrix metalloproteinases. , 1992, Chest.
[11] A. Kossakowska,et al. Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. , 1992, British Journal of Cancer.
[12] J. Foidart,et al. Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. , 1992, Cancer research.
[13] G. Raghu,et al. Production of collagenase and tissue inhibitor of metalloproteinases by fibroblasts derived from normal and fibrotic human lungs. , 1992, Chest.
[14] P. Bitterman. Pathogenesis of fibrosis in acute lung injury. , 1992, The American journal of medicine.
[15] L. Matrisian,et al. Negative regulation of gene expression by TGF‐β , 1992 .
[16] J. O'Connell,et al. The role of the C-terminal domain in collagenase and stromelysin specificity. , 1992, The Journal of biological chemistry.
[17] L. Matrisian,et al. The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. , 1992, The Journal of biological chemistry.
[18] M. Cockett,et al. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. , 1992, The Biochemical journal.
[19] W. Stetler-Stevenson,et al. Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. , 1992, Cancer research.
[20] A. Strongin,et al. Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase. , 1992, The Journal of biological chemistry.
[21] D. Lovett,et al. Proteinases and glomerular matrix turnover. , 1992, Kidney international.
[22] M. Fini,et al. COLLAGENOLYTIC/GELATINOLYTIC ENZYMES IN CORNEAL WOUND HEALING , 1992, Acta ophthalmologica. Supplement.
[23] T. Hurskainen,et al. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. , 1992, Cancer research.
[24] H. Shimada,et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. , 1992, Cancer research.
[25] E. Webb. Enzyme nomenclature 1992. Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes. , 1992 .
[26] C. Brinckerhoff,et al. Regulation of metalloproteinase gene expression: implications for osteoarthritis. , 1992, Critical reviews in eukaryotic gene expression.
[27] P. Herrlich,et al. Positive and negative regulation of collagenase gene expression. , 1992, Matrix (Stuttgart, Germany). Supplement.
[28] P. Slocombe,et al. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. , 1991, Biochimica et biophysica acta.
[29] K. Suzuki,et al. Substrate specificities and activation mechanisms of matrix metalloproteinases. , 1991, Biochemical Society transactions.
[30] E. Howard,et al. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. , 1991, The Journal of biological chemistry.
[31] F. Sánchez‐Madrid,et al. Mobilization of Gelatinase‐Rich Granules as a Regulatory Mechanism of Early Functional Responses in Human Neutrophils , 1991, Scandinavian journal of immunology.
[32] J. McDonald,et al. Cellular processes in lung repair. , 1991, Chest.
[33] M. Selman,et al. Collagenase and collagenase inhibitors in bronchoalveolar lavage fluids. , 1991, Chest.
[34] W. Hanlon,et al. rTNFa Facilitates Human Polymorphonuclear Leukocyte Adherence to Fibrinogen Matrices With Mobilization of Specific and Tertiary but Not Azurophilic Granule Markers , 2005 .
[35] H. Birkedal‐Hansen,et al. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. , 1991, The Journal of biological chemistry.
[36] G. Opdenakker,et al. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. , 1991, European journal of biochemistry.
[37] J. Wrana,et al. Induction of formative and resorptive cellular phenotypes in human gingival fibroblasts by TGF-beta 1 and concanavalin A: regulation of matrix metalloproteinases and TIMP. , 1991, Journal of periodontal research.
[38] T. Petty. Protease Mechanisms in the Pathogenesis of Acute Lung Injury , 1991, Annals of the New York Academy of Sciences.
[39] B. Coulombe,et al. Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. , 1991, Cancer research.
[40] E. Hay,et al. Cell Biology of Extracellular Matrix , 1988, Springer US.
[41] Z. Werb,et al. Extracellular Matrix Degradation , 1991 .
[42] G. Murphy. The regulation of connective tissue metalloproteinases by natural inhibitors. , 1991, Agents and actions. Supplements.
[43] U. Thorgeirsson,et al. Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. , 1990, The Journal of biological chemistry.
[44] K. Brew,et al. Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase. , 1990, Biochemistry.
[45] J M Davidson,et al. Biochemistry and turnover of lung interstitium. , 1990, The European respiratory journal.
[46] K. Ward,et al. Pulmonary disease progress in sarcoid patients with and without bronchoalveolar lavage collagenase. , 1990, The American review of respiratory disease.
[47] L. Liotta,et al. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. , 1990, The Journal of biological chemistry.
[48] B. Bresnihan,et al. Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease. , 1990, Thorax.
[49] J. P. Thompson,et al. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. , 1990, The Journal of biological chemistry.
[50] H. Birkedal‐Hansen,et al. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[51] M. Sporn,et al. Transforming Growth Factor‐β in Rheumatoid Arthritis , 1990 .
[52] G. Murphy,et al. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. , 1990, Annals of the rheumatic diseases.
[53] Z. Werb,et al. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. , 1990, The Journal of biological chemistry.
[54] L. Matrisian,et al. Metalloproteinases and their inhibitors in matrix remodeling. , 1990, Trends in genetics : TIG.
[55] B. Hogan,et al. Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. , 1990, Current topics in developmental biology.
[56] A. Eisen,et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.
[57] G. Murphy,et al. The role of plasminogen in cell-mediated collagen degradation. , 1989, Cell biology international reports.
[58] J. Wrana,et al. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. , 1989, Connective tissue research.
[59] J. Woessner,et al. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. , 1988, The Journal of biological chemistry.
[60] L. Matrisian,et al. Structure-function relationships in the collagenase family member transin. , 1988, The Journal of biological chemistry.
[61] R. Chapela,et al. Lung collagen metabolism and the clinical course of hypersensitivity pneumonitis. , 1988, Chest.
[62] A. van Breda,et al. Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis. , 1988, Thorax.
[63] J. Travis,et al. Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases , 1988, FEBS letters.
[64] C. Odlum,et al. Collagenase andfibronectin inbronchoalveolar lavage fluid inpatients withsarcoidosis , 1988 .
[65] P. Stephens,et al. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. , 1987, The Biochemical journal.
[66] H. Welgus,et al. Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. , 1987, The Journal of clinical investigation.
[67] H. Birkedal‐Hansen,et al. Sequence specificity of human skin fibroblast collagenase. Evidence for the role of collagen structure in determining the collagenase cleavage site. , 1987, The Journal of biological chemistry.
[68] J. Gadek,et al. Neutrophil collagenase in rheumatoid interstitial lung disease. , 1987, Journal of applied physiology.
[69] L. Boxer,et al. Association between gelatinase release and increased plasma membrane expression of the Mo1 glycoprotein. , 1987, Blood.
[70] T. Cawston,et al. Preferential binding of collagenase to α2‐macroglobulin in the presence of the tissue inhibitor of metalloproteinases , 1986, FEBS letters.
[71] S. Weiss,et al. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[72] J. Falloon,et al. Neutrophil granules in health and disease. , 1986, The Journal of allergy and clinical immunology.
[73] R. Chapela,et al. Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. , 1986, Thorax.
[74] L. Liotta,et al. Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. , 1986, The Journal of biological chemistry.
[75] P. Dorinsky,et al. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. , 1986, The American review of respiratory disease.
[76] A. Fein,et al. Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. , 2015, The American review of respiratory disease.
[77] J. Reynolds,et al. Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen. , 1985, Biochimica et biophysica acta.
[78] J. Seyer,et al. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. , 1985, The Journal of biological chemistry.
[79] G. Raghu,et al. Extracellular matrix in normal and fibrotic human lungs. , 1985, The American review of respiratory disease.
[80] A. Kang,et al. Secretion of collagenolytic enzymes by human polymorphonuclear leukocytes. , 1984, Collagen and related research.
[81] J. Seyer,et al. Purification of a type V collagen degrading metalloproteinase from rabbit alveolar macrophages. , 1984, Collagen and related research.
[82] R. Crystal,et al. Role of connective tissue proteases in the pathogenesis of chronic inflammatory lung disease. , 1984, Environmental health perspectives.
[83] R. Crystal,et al. Pulmonary asbestosis and idiopathic pulmonary fibrosis: pathogenetic parallels. , 1981, Chest.
[84] L. Liotta,et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.
[85] R. Crystal,et al. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. , 1979, The New England journal of medicine.
[86] J. Gallin,et al. Secretory responses of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo. , 1979, Journal of immunology.
[87] S. Krane,et al. An endopeptidase from rheumatoid synovial tissue culture. , 1972, Biochimica et biophysica acta.
[88] • Epidermis,et al. WOUND healing. , 1959, The Medical journal of Australia.